Literature DB >> 15483627

Regulation of nicotinic receptor expression by the ubiquitin-proteasome system.

John C Christianson1, William N Green.   

Abstract

Control of ligand-gated ion channel (LGIC) expression is essential for the formation, maintenance and plasticity of synapses. Treatment of mouse myotubes with proteasome inhibitors increased the number of surface nicotinic acetylcholine receptors (AChRs), indicating LGIC expression is regulated by the ubiquitin-proteasome system (UPS). Elevated surface expression resulted from increased AChR delivery to the plasma membrane and not from decreased turnover from the surface. The rise in AChR trafficking was the direct result of increased assembly of subunits in the endoplasmic reticulum (ER). Because proteasome inhibitors also blocked ER-associated degradation (ERAD) of unassembled AChR subunits, the data indicate that the additional AChRs were assembled from subunits normally targeted for ERAD. Our data show that AChR surface expression is regulated by the UPS through ERAD, whose activity determines oligomeric receptor assembly efficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483627      PMCID: PMC524400          DOI: 10.1038/sj.emboj.7600436

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  73 in total

1.  Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-Subunit.

Authors:  S H Keller; J Lindstrom; M Ellisman; P Taylor
Journal:  J Biol Chem       Date:  2001-02-15       Impact factor: 5.157

2.  Transient expression of heteromeric ion channels.

Authors:  A L Eertmoed; Y F Vallejo; W N Green
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

3.  Biosynthesis and processing of epithelial sodium channels in Xenopus oocytes.

Authors:  J A Valentijn; G K Fyfe; C M Canessa
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

4.  Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome.

Authors:  R K Plemper; R Egner; K Kuchler; D H Wolf
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

5.  Formation of the nicotinic acetylcholine receptor binding sites.

Authors:  W N Green; C P Wanamaker
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

Review 6.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways.

Authors:  J S Bonifacino; A M Weissman
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

7.  Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.

Authors:  M de Virgilio; H Weninger; N E Ivessa
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

8.  Degradation signal masking by heterodimerization of MATalpha2 and MATa1 blocks their mutual destruction by the ubiquitin-proteasome pathway.

Authors:  P R Johnson; R Swanson; L Rakhilina; M Hochstrasser
Journal:  Cell       Date:  1998-07-24       Impact factor: 41.582

9.  Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor.

Authors:  S H Keller; J Lindstrom; P Taylor
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

10.  Aggresomes: a cellular response to misfolded proteins.

Authors:  J A Johnston; C L Ward; R R Kopito
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

View more
  42 in total

1.  Incompatibility between a pair of residues from the pre-M1 linker and Cys-loop blocks surface expression of the glycine receptor.

Authors:  Qiang Shan; Joseph W Lynch
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  GABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptors.

Authors:  Randa S Eshaq; Letha D Stahl; Randolph Stone; Sheryl S Smith; Lucy C Robinson; Nancy J Leidenheimer
Journal:  Brain Res       Date:  2010-05-16       Impact factor: 3.252

Review 3.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

4.  Sorting receptor Rer1 controls surface expression of muscle acetylcholine receptors by ER retention of unassembled alpha-subunits.

Authors:  Christina Valkova; Marina Albrizio; Ira V Röder; Michael Schwake; Romeo Betto; Rüdiger Rudolf; Christoph Kaether
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

5.  The GABAA receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation.

Authors:  Martin J Gallagher; Li Ding; Ankit Maheshwari; Robert L Macdonald
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

6.  Role of the ubiquitin system in regulating ion transport.

Authors:  Daniela Rotin; Olivier Staub
Journal:  Pflugers Arch       Date:  2010-10-23       Impact factor: 3.657

Review 7.  Roles of ubiquitination at the synapse.

Authors:  Kevin F Haas; Kendal Broadie
Journal:  Biochim Biophys Acta       Date:  2008-01-05

Review 8.  Cellular trafficking of nicotinic acetylcholine receptors.

Authors:  Paul A St John
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

9.  Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture.

Authors:  Natasha Bajic; Peter Jenner; Clive G Ballard; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2012-05-17       Impact factor: 3.575

10.  Cadmium-mediated rescue from ER-associated degradation induces expression of its exporter.

Authors:  David J Adle; Wenzhong Wei; Nathan Smith; Joshua J Bies; Jaekwon Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.